Aimed Alliance sent a letter to Colorado Representative Ken DeGraaf regarding his special session bill, “Prescription Drug Benefit Information Transparency” (HB25B-1012).…
On October 3, the Colorado Prescription Drug Affordability Board (PDAB) voted to establish an upper payment limit (UPL) for Enbrel,…
On October 7, 2025, Aimed Alliance sent a follow-up letter to the U.S. Food and Drug Administration (FDA) regarding the…
Aimed Alliance submitted a comment to the Oregon Prescription Drug Affordability Board (PDAB) urging it to maintain a careful, evidence-based…
Aimed Alliance sent a letter to Colorado Representative Ken DeGraaf’s regarding his special session bill “Prescription Drug Benefit Information Transparency”…
On September 16, 2025, the Food and Drug Administration (FDA) issued a warning that many over-the-counter blood pressure devices lack…
Aimed Alliance has published a new resource highlighting pharmacy benefit manager (PBMs) practices and proposed reforms to ensure transparency in…
Following a May court ruling that pharmaceutical manufacturers must receive Health Resources and Services Administration (HRSA) approval before replacing upfront…
Beginning in January 2026, the Centers for Medicare & Medicaid Services (CMS) will launch the Wasteful and Inappropriate Service Reduction…
On July 28, Aimed Alliance sent a letter to the Centers for Consumer Information and Insurance Oversight (CCIIO) and the…